ReviewBiomedicines2026
Exploring Alzheimer Disease from a Retinal and Ocular Perspective.
Review in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Alzheimer disease (AD) is a neurodegenerative disorder currently recognized as the leading cause of dementia worldwide. It is characterized by a progressive cognitive decline, which can be studied and diagnosed through the use of various brain biomarkers. The retina, being part of the central nervous system, shares numerous structural and functional features with the brain. In this light, a wide range of alterations have been found in the retina with significant potential as biomarkers for AD diagnosis, even at early stages of its manifestation in the brain, and for monitoring disease progression within this organ. Furthermore, the detection of such alterations in the eye and retina is feasible through non-invasive, relatively simple and cost-effective techniques, such as optical coherence tomography, scanning laser ophthalmoscopy and electroretinography. Using these methods, numerous studies have identified molecular, morphological and functional changes associated with AD in the retina and other ocular elements, including the choroid, cornea, lens, intraocular humors and tear fluid. This review addresses the main anomalous changes identified to date in the retina and other eye structures in patients with AD, highlighting their potential utility as biomarkers for the diagnosis of this disease and their possible extrapolation to its prognosis in the brain.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.